|
KMID : 1141720220100010033
|
|
폐쇄성폐질환
2022 Volume.10 No. 1 p.33 ~ p.36
|
|
|
Current Issues on the Treatment of Mild Asthma
|
|
Shin Eun-Young
Kim Tae-Bum
|
|
|
Abstract
|
|
|
|
As needed low dose ICS/formoterol regimen was recommended as the preferred option in GINA 2021 for patients classified as mild asthma according to the severity classification of the Global Initiative for Asthma. Because this regimen is equivalent to ICS inhalation therapy in the prevention of acute exacerbations and has excellent patient compliance. However, GINA made it possible to select an alternative option in consideration of the individual characteristics of the patient. In this case, it is necessary for the clinician to continuously confirm the use of inhalants to lower the risk of SABA use alone. In addition, patients who used as-needed low-dose ICS/formoterol can use low-dose ICS/formoterol before exercise without additional prescribing SABA to prevent exercise-induced asthma.
|
|
|
KEYWORD
|
|
|
Mild asthma, As-needed low-dose ICS/formoterol
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|